Identification of cis-acting elements and splicing factors involved in the regulation of BIM pre-mRNA splicing

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Juan, Wen Chun ^a   Roca, Xavier ^b   Ong, S Tiong ^a,c,d,e  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL 2 LIKE 11; CIS ACTING ELEMENT; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN C; POLYPYRIMIDINE TRACT BINDING PROTEIN; POLYPYRIMIDINE TRACT BINDING PROTEIN 1; PROTEIN BCL 2; TRANS ACTING FACTOR; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BCL-2-LIKE PROTEIN 11; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HNRNPC PROTEIN, HUMAN; MEMBRANE PROTEIN; ONCOPROTEIN; PTBP1 PROTEIN, HUMAN; RNA PRECURSOR;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE DELETION; GENE EXPRESSION; GENE REPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; INTRON; PROMOTER REGION; PROTEIN PROCESSING; RNA PROCESSING; SILENCER ELEMENT; TRANSCRIPTION REGULATION; BIOSYNTHESIS; GENETICS; K562 CELL LINE; METABOLISM; PHYSIOLOGY;

ALTERNATIVE SPLICING; APOPTOSIS REGULATORY PROTEINS; EXONS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP C; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INTRONS; K562 CELLS; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; POLYPYRIMIDINE TRACT-BINDING PROTEIN; PROTO-ONCOGENE PROTEINS; RNA PRECURSORS;

EID: 84899695695     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095210     Document Type: Article

References (62)

1. Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-ordeath switch. Nature reviews Cancer 2: 647-656. (Pubitemid 37328916)
2. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE (2009) Cell death. The New England journal of medicine 361: 1570-1583.
3. Strasser A, Cory S, Adams JM (2011) Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. The EMBO journal 30: 3667-3683.
4. Youle RJ, Strasser A (2008) The BCL-2 protein family: opposing activities that mediate cell death. Nature reviews Molecular cell biology 9: 47-59.
5. Essafi A, Fernandez de Mattos, S, Hassen YA, Soeiro I, Mufti GJ, et al. (2005) Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24: 2317-2329. (Pubitemid 40546691)
6. Mestre-Escorihuela C, Rubio-Moscardo F, Richter JA, Siebert R, Climent J, et al. (2007) Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas. Blood 109: 271-280. (Pubitemid 46053067)
7. Kuroda J, Puthalakath H, Cragg MS, Kelly PN, Bouillet P, et al. (2006) Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proceedings of the National Academy of Sciences of the United States of America 103: 14907-14912. (Pubitemid 44527827)
8. Aichberger KJ, Mayerhofer M, Krauth MT, Vales A, Kondo R, et al. (2005) Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds. Cancer research 65: 9436-9444. (Pubitemid 41508012)
9. Costa DB, Halmos B, Kumar A, Schumer ST, Huberman MS, et al. (2007) BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations. PLoS medicine 4: 1669-1679; discussion 1680.
10. Cragg MS, Kuroda J, Puthalakath H, Huang DC, Strasser A (2007) Gefitinibinduced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics. PLoS medicine 4: 1681-1689; discussion 1690.
11. Qian L, Van Laake, LW, Huang Y, Liu S, Wendland MF, et al. (2011) miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. The Journal of experimental medicine 208: 549-560.
12. Ness JM, Harvey CA, Strasser A, Bouillet P, Klocke BJ, et al. (2006) Selective involvement of BH3-only Bcl-2 family members Bim and Bad in neonatal hypoxia-ischemia. Brain Res 1099: 150-159. (Pubitemid 44088651)
13. Biswas SC, Shi Y, Vonsattel JP, Leung CL, Troy CM, et al. (2007) Bim is elevated in Alzheimer's disease neurons and is required for beta-amyloidinduced neuronal apoptosis. The Journal of neuroscience: The official journal of the Society for Neuroscience 27: 893-900. (Pubitemid 46174510)
14. Lauer C, Brunner T, Corazza N (2012) The proapoptotic Bcl-2 family member Bim plays a central role during the development of virus-induced hepatitis. J Immunol 188: 916-922.
15. Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, et al. (2007) Multiple triggers of cell death in sepsis: death receptor and mitochondrialmediated apoptosis. FASEB J 21: 708-719. (Pubitemid 46348247)
16. Ng KP, Hillmer AM, Chuah CT, Juan WC, Ko TK, et al. (2012) A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer. Nature medicine 18: 521-528.
17. Anczukow O, Rosenberg AZ, Akerman M, Das S, Zhan L, et al. (2012) The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nature structural & molecular biology 19: 220-228.
18. Gagne V, Rousseau J, Labuda M, Sharif-Askari B, Brukner I, et al. (2013) Bim polymorphisms: influence on function and response to treatment in children with acute lymphoblastic leukemia. Clinical cancer research: An official journal of the American Association for Cancer Research 19: 5240-5249.
19. Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463: 457-463.
20. Ward AJ, Cooper TA (2010) The pathobiology of splicing. The Journal of pathology 220: 152-163.
21. Sheth N, Roca X, Hastings ML, Roeder T, Krainer AR, et al. (2006) Comprehensive splice-site analysis using comparative genomics. Nucleic acids research 34: 3955-3967. (Pubitemid 44391011)
22. Wang GS, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nature reviews Genetics 8: 749-761. (Pubitemid 47429207)
23. Black DL (2003) Mechanisms of alternative pre-messenger RNA splicing. Annual review of biochemistry 72: 291-336. (Pubitemid 36930448)
24. Zhou Z, Fu XD (2013) Regulation of splicing by SR proteins and SR proteinspecific kinases. Chromosoma 122: 191-207.
25. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, et al. (1998) Bim: A novel member of the Bcl-2 family that promotes apoptosis. The EMBO journal 17: 384-395. (Pubitemid 28045479)
26. Wagner EJ, Garcia-Blanco MA (2002) RNAi-mediated PTB depletion leads to enhanced exon definition. Molecular cell 10: 943-949. (Pubitemid 35335648)
27. Paz I, Akerman M, Dror I, Kosti I, Mandel-Gutfreund Y (2010) SFmap: A web server for motif analysis and prediction of splicing factor binding sites. Nucleic acids research 38: 281-285.
28. Zhang XH, Chasin LA (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes & development 18: 1241-1250. (Pubitemid 38720592)
29. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, et al. (2009) Human Splicing Finder: An online bioinformatics tool to predict splicing signals. Nucleic acids research 37: e67.
30. Piva F, Giulietti M, Nocchi L, Principato G (2009) Splice Aid: A database of experimental RNA target motifs bound by splicing proteins in humans. Bioinformatics 25: 1211-1213.
31. Carstens RP, Wagner EJ, Garcia-Blanco MA (2000) An intronic splicing silencer causes skipping of the IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Molecular and cellular biology 20: 7388-7400.
32. Chan RC, Black DL (1997) The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Molecular and cellular biology 17: 4667-4676. (Pubitemid 27318142)
33. Mulligan GJ, Guo W, Wormsley S, Helfman DM (1992) Polypyrimidine tract binding protein interacts with sequences involved in alternative splicing of betatropomyosin pre-mRNA. The Journal of biological chemistry 267: 25480- 25487.
34. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, et al. (2010) iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nature structural & molecular biology 17: 909-915.
35. Han K, Yeo G, An P, Burge CB, Grabowski PJ (2005) A combinatorial code for splicing silencing: UAGG and GGGG motifs. PLoS biology 3: e158.
36. Zhu J, Mayeda A, Krainer AR (2001) Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. Molecular cell 8: 1351-1361. (Pubitemid 34086947)
37. Pagani F, Stuani C, Tzetis M, Kanavakis E, Efthymiadou A, et al. (2003) New type of disease causing mutations: The example of the composite exonic regulatory elements of splicing in CFTR exon 12. Human molecular genetics 12: 1111-1120. (Pubitemid 36622143)
38. Mauger DM, Lin C, Garcia-Blanco MA (2008) hnRNP H and hnRNP F complex with Fox2 to silence fibroblast growth factor receptor 2 exon IIIc. Molecular and cellular biology 28: 5403-5419.
39. Wentz MP, Moore BE, Cloyd MW, Berget SM, Donehower LA (1997) A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production. Journal of virology 71: 8542-8551. (Pubitemid 27446436)
40. Zheng ZM, He P, Baker CC (1996) Selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site is regulated through an exonic splicing enhancer and its juxtaposed exonic splicing suppressor. Journal of virology 70: 4691-4699. (Pubitemid 26187463)
41. Lalonde E, Ha KC, Wang Z, Bemmo A, Kleinman CL, et al. (2011) RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression. Genome research 21: 545-554.
42. Lu ZX, Jiang P, Xing Y (2012) Genetic variation of pre-mRNA alternative splicing in human populations. Wiley interdisciplinary reviews RNA 3: 581-592.
43. Roca X, Olson AJ, Rao AR, Enerly E, Kristensen VN, et al. (2008) Features of 5'-splice-site efficiency derived from disease-causing mutations and comparative genomics. Genome research 18: 77-87.
44. Nembaware V, Wolfe KH, Bettoni F, Kelso J, Seoighe C (2004) Allele-specific transcript isoforms in human. FEBS letters 577: 233-238. (Pubitemid 39452390)
45. Goguel V, Wang Y, Rosbash M (1993) Short artificial hairpins sequester splicing signals and inhibit yeast pre-mRNA splicing. Molecular and cellular biology 13: 6841-6848. (Pubitemid 23321137)
46. Cornelis S, Tinton SA, Schepens B, Bruynooghe Y, Beyaert R (2005) UNR translation can be driven by an IRES element that is negatively regulated by polypyrimidine tract binding protein. Nucleic acids research 33: 3095-3108. (Pubitemid 41194454)
47. Mitchell SA, Brown EC, Coldwell MJ, Jackson RJ, Willis AE (2001) Protein factor requirements of the Apaf-1 internal ribosome entry segment: roles of polypyrimidine tract binding protein and upstream of N-ras. Molecular and cellular biology 21: 3364-3374. (Pubitemid 32381772)
48. Coutinho-Mansfield GC, Xue Y, Zhang Y, Fu XD (2007) PTB/nPTB switch: A post-transcriptional mechanism for programming neuronal differentiation. Genes & development 21: 1573-1577. (Pubitemid 47026360)
49. Lefave CV, Squatrito M, Vorlova S, Rocco GL, Brennan CW, et al. (2011) Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas. The EMBO journal 30: 4084-4097.
50. Crawford JB, Patton JG (2006) Activation of alpha-tropomyosin exon 2 is regulated by the SR protein 9G8 and heterogeneous nuclear ribonucleoproteins H and F. Molecular and cellular biology 26: 8791-8802. (Pubitemid 44851939)
51. Chen CD, Kobayashi R, Helfman DM (1999) Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. Genes & development 13: 593-606. (Pubitemid 29131883)
52. Masuda A, Shen XM, Ito M, Matsuura T, Engel AG, et al. (2008) hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndrome. Human molecular genetics 17: 4022-4035. (Pubitemid 352770203)
53. Caputi M, Zahler AM (2002) SR proteins and hnRNP H regulate the splicing of the HIV-1 tev-specific exon 6D. The EMBO journal 21: 845-855. (Pubitemid 34174064)
54. Chou MY, Rooke N, Turck CW, Black DL (1999) hnRNP H is a component of a splicing enhancer complex that activates a c-src alternative exon in neuronal cells. Molecular and cellular biology 19: 69-77. (Pubitemid 29018410)
55. Garneau D, Revil T, Fisette JF, Chabot B (2005) Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-x. The Journal of biological chemistry 280: 22641- 22650. (Pubitemid 40853168)
56. Wang E, Dimova N, Cambi F (2007) PLP/DM20 ratio is regulated by hnRNPH and F and a novel G-rich enhancer in oligodendrocytes. Nucleic acids research 35: 4164-4178. (Pubitemid 47244636)
57. Cragg MS, Harris C, Strasser A, Scott CL (2009) Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev Cancer 9: 321- 326.
58. Wiggins CM, Johnson M, Cook SJ (2010) Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIM. Cellular signalling 22: 801-808.
59. Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, et al. (2003) Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 22: 6785-6793. (Pubitemid 37372218)
60. Hubner A, Barrett T, Flavell RA, Davis RJ (2008) Multisite phosphorylation regulates Bim stability and apoptotic activity. Molecular cell 30: 415-425. (Pubitemid 351672377)
61. He X, Pool M, Darcy KM, Lim SB, Auersperg N, et al. (2007) Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene 26: 4961-4968. (Pubitemid 47172653)
62. Ke S, Chasin LA (2011) Context-dependent splicing regulation: exon definition, co-occurring motif pairs and tissue specificity. RNA biology 8: 384-388.